EUR 25.05
(0.2%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 38.67 Million EUR | 6.61% |
2022 | 30.44 Million EUR | -17.22% |
2021 | 36.78 Million EUR | 5.18% |
2020 | 34.97 Million EUR | -33.97% |
2019 | 52.96 Million EUR | -19.86% |
2018 | 66.09 Million EUR | -18.42% |
2017 | 81.01 Million EUR | 44.65% |
2016 | 56 Million EUR | -6.67% |
2015 | 60 Million EUR | 53.13% |
2014 | 39.18 Million EUR | 42.36% |
2013 | 27.52 Million EUR | -12.99% |
2012 | 31.63 Million EUR | 40.39% |
2011 | 22.53 Million EUR | 172.26% |
2010 | 8.27 Million EUR | -72.15% |
2009 | 29.72 Million EUR | -25.34% |
2008 | 39.81 Million EUR | 8.21% |
2007 | 36.79 Million EUR | 20.08% |
2006 | 30.64 Million EUR | -11.6% |
2005 | 34.65 Million EUR | 12.44% |
2004 | 30.82 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 30.27 Million EUR | 0.0% |
2023 FY | 32.46 Million EUR | 6.61% |
2023 Q2 | 10.61 Million EUR | 0.0% |
2023 Q4 | 28.84 Million EUR | 0.0% |
2022 FY | 30.44 Million EUR | -17.22% |
2022 Q4 | -41.31 Million EUR | 0.0% |
2022 Q2 | 13.58 Million EUR | 0.0% |
2021 Q4 | 3.69 Million EUR | 0.0% |
2021 Q2 | 34.18 Million EUR | 0.0% |
2021 FY | 36.78 Million EUR | 5.18% |
2020 Q4 | 14.1 Million EUR | 0.0% |
2020 Q2 | 21.36 Million EUR | 0.0% |
2020 FY | 34.97 Million EUR | -33.97% |
2019 Q4 | 29.47 Million EUR | 0.0% |
2019 Q2 | 22.26 Million EUR | 0.0% |
2019 FY | 52.96 Million EUR | -19.86% |
2018 Q4 | 29.47 Million EUR | 0.0% |
2018 Q2 | 36.62 Million EUR | 0.0% |
2018 FY | 66.09 Million EUR | -18.42% |
2017 FY | 81.01 Million EUR | 44.65% |
2017 Q2 | 40.67 Million EUR | 0.0% |
2017 Q4 | 40.33 Million EUR | 0.0% |
2016 FY | 56 Million EUR | -6.67% |
2016 Q2 | 26.3 Million EUR | 0.0% |
2016 Q4 | 29.69 Million EUR | 0.0% |
2015 Q4 | 30.08 Million EUR | 0.0% |
2015 Q2 | 29.92 Million EUR | 0.0% |
2015 FY | 60 Million EUR | 53.13% |
2014 FY | 39.18 Million EUR | 42.36% |
2014 Q4 | 20.13 Million EUR | 0.0% |
2014 Q2 | 19.05 Million EUR | 0.0% |
2013 Q2 | 15.12 Million EUR | 0.0% |
2013 Q4 | 12.39 Million EUR | 0.0% |
2013 FY | 27.52 Million EUR | -12.99% |
2012 Q1 | 7.52 Million EUR | 0.0% |
2012 FY | 31.63 Million EUR | 40.39% |
2012 Q4 | 7.26 Million EUR | -3.41% |
2012 Q3 | 7.52 Million EUR | 0.0% |
2012 Q2 | 7.52 Million EUR | 0.0% |
2011 FY | 22.53 Million EUR | 172.26% |
2011 Q3 | 5.53 Million EUR | 0.0% |
2011 Q1 | 5.53 Million EUR | 0.0% |
2011 Q2 | 5.53 Million EUR | 0.0% |
2011 Q4 | 7.52 Million EUR | 35.79% |
2010 Q1 | 1.94 Million EUR | 0.0% |
2010 Q3 | 1.94 Million EUR | 0.0% |
2010 FY | 8.27 Million EUR | -72.15% |
2010 Q4 | 5.53 Million EUR | 184.89% |
2010 Q2 | 1.94 Million EUR | 0.0% |
2009 Q3 | 7.38 Million EUR | 0.0% |
2009 Q1 | 7.38 Million EUR | 0.0% |
2009 FY | 29.72 Million EUR | -25.34% |
2009 Q4 | 1.94 Million EUR | -73.66% |
2009 Q2 | 7.38 Million EUR | 0.0% |
2008 Q3 | 9.87 Million EUR | 0.0% |
2008 Q2 | 9.87 Million EUR | 0.0% |
2008 Q1 | 9.87 Million EUR | 0.0% |
2008 FY | 39.81 Million EUR | 8.21% |
2008 Q4 | 7.38 Million EUR | -25.28% |
2007 Q4 | 9.87 Million EUR | 7.44% |
2007 Q3 | 9.19 Million EUR | 0.0% |
2007 Q2 | 9.19 Million EUR | 0.0% |
2007 Q1 | 9.19 Million EUR | 0.0% |
2007 FY | 36.79 Million EUR | 20.08% |
2006 Q1 | 7.14 Million EUR | 0.0% |
2006 FY | 30.64 Million EUR | -11.6% |
2006 Q3 | 7.14 Million EUR | 0.0% |
2006 Q2 | 7.14 Million EUR | 0.0% |
2006 Q4 | 9.19 Million EUR | 28.61% |
2005 Q1 | 9.54 Million EUR | 0.0% |
2005 Q4 | 7.14 Million EUR | -25.07% |
2005 Q3 | 9.54 Million EUR | 0.0% |
2005 Q2 | 9.54 Million EUR | 0.0% |
2005 FY | 34.65 Million EUR | 12.44% |
2004 FY | 30.82 Million EUR | 0.0% |
2004 Q2 | 7.34 Million EUR | 0.0% |
2004 Q1 | 7.34 Million EUR | 0.0% |
2004 Q3 | 7.34 Million EUR | 0.0% |
2004 Q4 | 9.54 Million EUR | 29.93% |
2003 Q4 | 7.34 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Affluent Medical SA | -13.06 Million EUR | 395.967% |
Bluelinea Société Anonyme | -1.61 Million EUR | 2497.958% |
Carmat SA | -52.51 Million EUR | 173.632% |
Diagnostic Medical Systems S.A. | -2.26 Million EUR | 1807.329% |
Euromedis Groupe | -5.55 Million EUR | 795.873% |
Eurobio Scientific Société anonyme | 10.14 Million EUR | -281.333% |
Ikonisys S.A. | -2.19 Million EUR | 1862.798% |
Implanet S.A. | -6.15 Million EUR | 727.878% |
Median Technologies SA | -23 Million EUR | 268.091% |
SpineGuard SA | -3.97 Million EUR | 1072.587% |
Theraclion SA | -3.15 Million EUR | 1326.094% |
Euroapi S.A. | -234.3 Million EUR | 116.505% |
Ion Beam Applications SA | 5.09 Million EUR | -659.446% |
Koninklijke Philips N.V. | -115 Million EUR | 133.627% |
Sequana Medical NV | -29.49 Million EUR | 231.126% |